ROCHESTER, Minn.-Between 200 and 300 Southeastern Minnesota residents were at Rochester Community and Technical Colleges' ...

The legal activity swirling around MyPillow CEO Mike Lindell now includes an investigation into his charities by the Minnesota Attorney General’s Office. Documents filed in Ramsey County District ...

Over 200 Med City residents packed RCTC's campus for Attorney General Keith Ellison's town hall meeting on Saturday, ...

Here's why La Roche-Posay is pulling its Effaclar Duo Acne Spot Treatment from retail shelves. La Roche-Posay is a brand under the L'Oreal Group umbrella. A La Roche-Posay spokesperson confirmed ...

Minnesota’s Attorney General Kieth Ellison and several DFL house representatives and senators to hear from the community and discuss several key topics.

The products are being recalled by the FDA for possible "benzene contamination." Acne creams from retailers including Walgreens, La Roche-Posay and Proactiv have been voluntarily recalled due to ...

Proactiv Skin Smoothing Exfoliator and La Roche-Posay Effaclar Duo Dual Action Acne Treatment. The full list and lot numbers was posted online Tuesday. “Even with daily use of these products for ...

At the 2023 Players Championship, Keith Mitchell produced one of the funniest moments in professional golf history. It was late in the day, with darkness about to settle in and a suspension of ...

We explore the history of global pharmaceutical group Hoffmann-La Roche from where it first began, to its core structure and its focus for the future in personalised medicine. Roche was found in ...

Minnesota Democratic-Farmer-Labor (DFL) candidate David Gottfried has won the special election for a seat in the Minnesota House, according to a Decision Desk HQ projection. Gottfried, a pro bono ...

Minnesota fired men's basketball coach Ben Johnson on Thursday after four years of repeatedly rebuilding rosters at his alma mater without coming close to an NCAA tournament appearance as the ...

Data from a phase 2 trial of Roche's oral BTK inhibitor fenebrutinib have shown "near-complete suppression" of disease activity and disability progression in relapsing multiple sclerosis (MS).